Reply to thread

Message: [QUOTE="greenmedinfo, post: 5419"] PMID: Planta Med. 2020 Aug ;86(12):876-883. Epub 2020 Jul 9. PMID: 32645736 Abstract Title: Syzygium aromaticum Reduces Diabetes-induced Glucotoxicity via the NRF2/Glo1 Pathway. Abstract: Advanced glycation end products and methylglyoxal are known to show increased levels in diabetic conditions and induce diverse metabolic disorders. However, the antiglycation ability of the bark ofis not yet studied. In this study, we determined the inhibitory effects ofon AGE formation. Moreover,showed breakage and inhibitory ability against the formation of AGE-collagen crosslinks. In SV40 MES13 cells, treatment with theextract significantly ameliorated MG-induced oxidative stress as well as cytotoxicity. Furthermore, in theextract-treated group, there was a reduction in levels of several diabetic markers, such as blood glucose, kidney weight, and urinary albumin to creatinine ratio in streptozotocin-induced diabetic rats. Treatment with theextract significantly increased the expression of nuclear factor erythroid 2-related factor 2, a transcription factor involved in the expression of antioxidant enzymes. Moreover, the treatment significantly upregulated the expression of glyoxalase 1 and downregulated the expression of receptor for AGEs. These results suggest that theextract might ameliorate diabetes-induced renal damage by inhibiting the AGE-induced glucotoxicity and oxidative stress through the Nrf2/Glo1 pathway. [URL='https://www.greenmedinfo.com/article/syzygium-aromaticum-reduces-diabetes-induced-glucotoxicity-nrf2glo1-pathway']read more[/URL] [/QUOTE]

Verification

Top Bottom

Search

Search

Reply to thread